Obalon Therapeutics Inc.

NASDAQ: OBLN · Real-Time Price · USD
3.05
-0.19 (-5.86%)
At close: Jun 16, 2021, 6:00 AM

Obalon Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2021 Q1 2021
Period Ending Jun 30, 2021 Mar 31, 2021
Net Income
-3.9K -4.17M
Depreciation & Amortization
-126K 166K
Stock-Based Compensation
-354K 91K
Other Working Capital
-1.86M 3.17M
Other Non-Cash Items
1.6M -3.67M
Deferred Income Tax
n/a n/a
Change in Working Capital
-822K 3.14M
Operating Cash Flow
293K -4.44M
Capital Expenditures
-196K n/a
Cash Acquisitions
n/a n/a
Purchase of Investments
n/a n/a
Sales Maturities Of Investments
n/a n/a
Other Investing Acitivies
5.21M n/a
Investing Cash Flow
5.01M n/a
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
26.82M 9.51M
Financial Cash Flow
26.82M 9.51M
Net Cash Flow
31.24M 5.07M
Free Cash Flow
97K -4.44M